YD Bio Ltd Files SEC Form
YD Bio Ltd submits filing to SEC
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.
Related stories
Schneider National Reports Q3 Revenue of $1.59B
Q3 revenue was $1.59 billion, compared with a FactSet estimate of $1.58 billion.
M impact | EQUITY | Oct 29, 2026, 08:30 PM UTC
Universal Logistics Reports Third-Quarter 2026 Financial Results, Declares Dividend
Universal Logistics reported operating revenue of $394.0 million, operating income of $32.8 million and net income of $18…
M impact | EQUITY | Oct 29, 2026, 08:22 PM UTC
Supernus Reports Q3 Revenue of $226.8 Million, Up 18%
Supernus reported third-quarter 2026 net earnings of $20.9 million and operating income of $21.2 million, versus an operating loss a year earlier. It also raised its standalone ful
M impact | EQUITY | Oct 29, 2026, 08:21 PM UTC
Immuneering Reports $24.2 Million Q3 Net Loss, Cash Runway Into Q4 2028
Immuneering reported a third-quarter 2026 net loss of $24.2 million, or $0.37 per share, versus a $15.0 million loss a year earlier. Cash, cash equivalents and marketable securitie
M impact | EQUITY | Oct 29, 2026, 08:21 PM UTC
Forrester Research Q3 Revenue and Adjusted EPS Fall
M impact | EQUITY | Oct 29, 2026, 08:21 PM UTC
RealReal Q3 Revenue Beats Analyst Estimates on Order Growth
M impact | EQUITY | Oct 29, 2026, 08:21 PM UTC